ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,887Medicare Part D Prescriptions Filled, Including Refills

Rank: 249 out of 1107

$680K Total Retail Price of All Prescriptions

Rank: 230 out of 1107

430 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 430 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 8,851 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
SIMVASTATIN 448 348 1 5
AMLODIPINE BESYLATE 407 378 2 6
LEVOTHYROXINE SODIUM 385 318 3 3
LISINOPRIL 384 290 4 2
ATORVASTATIN CALCIUM 322 283 5 13
ATENOLOL 278 238 6 19
METFORMIN HCL 267 184 7 8
METOPROLOL TARTRATE 249 207 8 10
GLIMEPIRIDE 241 181 9 43
GABAPENTIN 236 139 10 9
RANITIDINE HCL 236 167 10 21
HYDROCHLOROTHIAZIDE 235 190 12 11
CRESTOR 202 86 13 23
FUROSEMIDE 200 164 14 7
METFORMIN HCL ER 199 120 15 58
OMEPRAZOLE 189 143 16 4
PRAVASTATIN SODIUM 168 131 17 12
HYDROCODONE-ACETAMINOPHEN 162 120 S3 18 1
TRAMADOL HCL 136 89 19 26
NEXIUM 135 64 20 18
MELOXICAM 128 113 21 25
PAROXETINE HCL 124 94 22 45
CLOPIDOGREL 120 99 23 28
TAMSULOSIN HCL 120 108 23 30
WARFARIN SODIUM 119 92 25 15
PANTOPRAZOLE SODIUM 113 84 26 30
ISOSORBIDE MONONITRATE ER 106 101 27 34
SYNTHROID 105 82 28 70
CITALOPRAM HBR 102 47 29 17
BENAZEPRIL HCL 102 78 29 86
ACTOS 98 72 31 132
PLAVIX 97 83 32 39
METOPROLOL SUCCINATE 96 65 33 16
CARVEDILOL 96 71 33 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 70 33 24
JANUVIA 95 91 36 60
CELEBREX 85 54 37 85
DICLOFENAC SODIUM 85 66 37 74
DOXAZOSIN MESYLATE 79 69 39 92
POTASSIUM CHLORIDE 79 70 39 14
AZITHROMYCIN 77 41 41 35
DONEPEZIL HCL 76 76 42 32
AMITRIPTYLINE HCL 75 40 R 43 48
TRILIPIX 73 49 44 153
SERTRALINE HCL 72 50 45 20
DIOVAN 71 60 46 51
LOSARTAN POTASSIUM 70 58 47 29
ENALAPRIL MALEATE 67 67 48 98
SPIRONOLACTONE 62 36 49 72
NAPROXEN 61 43 50 80
IBUPROFEN 58 18 51 63
GLYBURIDE 58 47 R 51 68
LIPITOR 55 46 53 109
LANSOPRAZOLE 55 52 53 102
AMLODIPINE BESYLATE-BENAZEPRIL 54 54 55 77
NAMENDA 53 53 56 42
LOVAZA 53 43 56 101
POLYETHYLENE GLYCOL 3350 53 46 56 46
SPIRIVA 52 39 59 57
SINGULAIR 50 38 60 65
TIZANIDINE HCL 50 31 60 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.